Two CureVac vaccine patents invalidated in UK branch of global dispute with Pfizer, BioNTech
Two of German drugmaker CureVac’s patents associated with technology used in making Covid-19 vaccines were declared invalid by a UK court today on grounds of "insufficiency and obviousness." US pharmaceutical giant...To view the full article, register now.
Already a subscriber? Click here to view full article